Fingerstick glucometers on a cost per vial basis for RMR, OKC and musk. Year three funding.
Ended Awarded Last action
- Contract number
- 36C25924N0260
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $77,461
Award facts
- Contract value 100% obligated
- $77,460.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$23,568 | |
| Supplemental Agreement for work within scope | -$5,364 | |
| Supplemental Agreement for work within scope | -$117 | |
| Original award | $106,510 |
About this award
Roche Diagnostics Corporation was awarded a $77.46K firm fixed-price blanket purchase agreement (BPA) call for fingerstick glucometers on a cost-per-vial basis, serving three Veterans Health Administration facilities: the Ralph M. Russ Veterans Medical Center (RMR) in Oklahoma City, the Veterans Medical Center (MUSK), and the Oklahoma City VA Medical Center. This award represents Year Three funding and was issued on May 1, 2024, with a completion date of April 30, 2025. The contract is not subject to a set-aside designation and falls under the scope of services provided through Veterans Integrated Service Network 19 (VISN 19), a regional network within the Department of Veterans Affairs responsible for delivering healthcare to veterans across a multi-state area.
As a child contract to a larger vehicle, this BPA call leverages Roche Diagnostics' established supply relationship with the VA for diagnostic medical devices and reagents. Roche Diagnostics Corporation, a global leader in in vitro diagnostics and point-of-care testing solutions, routinely supplies the federal healthcare system with laboratory equipment, testing systems, and clinical consumables. The provision of fingerstick glucometers supports diabetes management and monitoring across the three VA facilities, enabling veterans to conduct rapid point-of-care glucose testing for improved disease management and clinical outcomes.
Quick answers
Who was awarded contract 36C25924N0260?
36C25924N0260 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 19 (Veterans Health Administration) on May 1, 2024.
How much is contract 36C25924N0260 worth?
The government has obligated $77,461 on 36C25924N0260.
Is contract 36C25924N0260 an order under another contract?
Yes. 36C25924N0260 is a BPA call under 36C25922A0017, a blanket purchase agreement.
Was contract 36C25924N0260 competed?
The extent of competition for 36C25924N0260 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award